NCT02568787View on ClinicalTrials.gov

The Effect of an RBAC Supplement (BRM4) on NAFLD

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

June 10, 2017

Study Completion Date

June 10, 2017

Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
DIETARY_SUPPLEMENT

rice bran arabinoxylan compound (RBAC)

Take 2 tablets 1 time (1 gram) per day for the 3-month intervention period.

DIETARY_SUPPLEMENT

Placebo

Take 2 tablets 1 time (1 gram) per day for the 3-month intervention period.

Trial Locations (1)

33136-2107

University of Miami Miller School of Medicine, Soffer Clinical Research Center, Department of Psychiatry & Behavioral Sciences, Miami

All Listed Sponsors
collaborator

Daiwa Health Development

OTHER

lead

University of Miami

OTHER

NCT02568787 - The Effect of an RBAC Supplement (BRM4) on NAFLD | Biotech Hunter | Biotech Hunter